M. Derosa et al., SHORT STATURE AND AZOOSPERMIA IN A PATIENT WITH Y-CHROMOSOME LONG ARMDELETION, Journal of endocrinological investigation, 20(10), 1997, pp. 623-628
We report on a 42-year old male with short stature, azoospermia and a
wide deletion of long arm of Y chromosome. On physical examination, th
e patient showed height of 149 cm (<1 degrees centile) and reduced vol
ume (3 ml) and consistency of the testes. On hormonal evaluation, he s
howed increased serum gonadotropins and normal serum testosterone leve
ls though its HCG stimulated levels were limited. Serum thyroid hormon
es were normal. Serum GH levels in baseline evaluation as well as afte
r GHRH and GHRH + pyridostigmine administration were normal. Serum IGF
I levels were lower than normal in baseline evaluation whereas its re
sponse to the GH administration was in the normal range. The bilateral
testicular biopsy showed tubular atrophy, hyalinosis, interstitial sc
lerosis and a histological picture of a Sertoli cell only syndrome. Mo
reover the patient showed arthropathy, otopathy, small chin, small mou
th and truncal obesity, On genetic evaluation, the patient showed a 46
,X,delY(pter-->q11.1:) karyotype and loss of several DNA loci on Yq, I
n fact he preserved short arm SRY, centromeric DYZ3 and more proximal
euchromatic region Yq loci, including DYS270, DYS271, DYS272, DYS11, D
YS273, DYS274, DYS148, DYS275, and missed more distal DNA loci from DY
S246 to DYZ2. These results disclosed a wide Y long arm deletion, incl
uding all hypothized Yq azoospermia loci (except for AZFa and probably
for one of the RBM genes, which lie proximally to the deletion) and p
ossibly the Y-specific growth control region (GCY), mapped between DYS
11 and DYS246 loci. This deletion is responsible for the complete azoo
spermia of the patient and probably also for his short stature, even i
f other factors could be implicated in the statural impairment, It fur
ther possibly allowed to relate the GCY gene(s) to the control of GH o
r IGF-I receptor or post-receptor pathway, being the alteration of thi
s gene(s) consistent with the hormonal pattern of the patient. (C) 199
7, Editrice Kurtis.